Design and synthesis of 1H-pyrazolo[3,4-c]pyridine derivatives as a novel structural class of potent GPR119 agonists
Daisuke Matsuda(Taisho Pharmaceutical (Japan)), Norikazu Ohtake(Taisho Pharmaceutical (Japan)), Koji Oda(Tokyo Metropolitan University), Hiroyuki Kakinuma(Taisho Pharmaceutical (Japan)), Yohei Kobashi(Taisho Pharmaceutical (Japan)), Fumiyasu Shiozawa(Taisho Pharmaceutical (Japan)), Kenichi Kawabe(Taisho Pharmaceutical (Japan)), Noriko Takayama(Taisho Pharmaceutical (Japan)), Shinichi Nishimoto(Taisho Pharmaceutical (Japan)), Makoto Hamada(Taisho Pharmaceutical (Japan)), Masako Miyoshi(Taisho Pharmaceutical (Japan)), Ayako Mikami(Taisho Pharmaceutical (Japan)), Kayo Kimura(Taisho Pharmaceutical (Japan)), Madoka Kawamura(Kyushu University)
Cited by 19
Related Papers
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience
|Journal of Hepato-Biliary-Pancreatic Surgery|2000|396
Intraductal papillary neoplasia of the liver associated with hepatolithiasis
|Hepatology|2001|282
<scp>l</scp>‐Type amino acid transporter 1 inhibitors inhibit tumor cell growth
|Cancer Science|2009|271
Management of Hilar Cholangiocarcinoma
|Annals of Surgery|2000|259
Surgical Anatomy of the Bile Ducts at the Hepatic Hilum as Applied to Living Donor Liver Transplantation
|Annals of Surgery|2003|203